Related Experiment Video
Updated: Sep 5, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Inhibition of GSDMD Activates Poly(ADP-ribosyl)ation and Promotes Myocardial Ischemia-Reperfusion Injury
Zheng-Hao Zhang1, Zi-Guan Zhang1, Min-Wei Chen1
1Department of Cardiology, Xiamen Key Laboratory of Cardiac Electrophysiology, Xiamen Institute of Cardiovascular Diseases, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Abstract:
The precise control of cardiomyocyte viability is imperative to combat myocardial ischemia-reperfusion injury (I/R), in which apoptosis and pyroptosis putatively contribute to the process. Recent researches indicated that GSDMD is involved in I/R as an executive protein of pyroptosis. However, its effect on other forms of cell death is unclear. We identified that GSDMD and GSDMD-N levels were significantly upregulated in the I/R myocardium of mice. Knockout of GSDMD conferred the resistance of the hearts to reperfusion injury in the acute phase of I/R but aggravated reperfusion injury in the chronic phase of I/R. Mechanistically, GSDMD deficiency induced the activation of PARylation and the consumption of NAD+ and ATP, leading to cardiomyocyte apoptosis. Moreover, PJ34, a putative PARP-1 inhibitor, reduced the myocardial injury caused by GSDMD deficiency. Our results reveal a novel action modality of GSDMD in the regulation of cardiomyocyte death; inhibition of GSDMD activates PARylation, suggesting the multidirectional role of GSDMD in I/R and providing a new theory for clinical treatment.
Insights
Gasdermin D (GSDMD) plays a dual role in heart reperfusion injury. Inhibiting GSDMD initially protects the heart but later worsens injury by promoting apoptosis.
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Molecular Medicine
Background:
- Myocardial ischemia-reperfusion (I/R) injury involves complex cell death pathways, including apoptosis and pyroptosis.
- Gasdermin D (GSDMD) is recognized as a key executioner protein in pyroptosis, but its broader role in I/R is not fully understood.
Purpose of the Study:
- To investigate the role of GSDMD in regulating cardiomyocyte viability during myocardial I/R.
- To elucidate the mechanisms by which GSDMD influences different cell death modalities in I/R.
Main Methods:
- Analysis of GSDMD and GSDMD-N expression in a mouse model of myocardial I/R.
- Assessment of cardiac function and injury in GSDMD knockout mice during acute and chronic I/R.
- Investigation of molecular pathways, including PARylation, NAD+, and ATP consumption, in GSDMD-deficient hearts.
- Evaluation of the therapeutic effect of a PARP-1 inhibitor (PJ34).
Main Results:
- GSDMD and its N-terminal fragment were significantly upregulated in I/R myocardium.
- GSDMD knockout provided acute protection against I/R but exacerbated injury in the chronic phase.
- GSDMD deficiency led to increased PARylation, NAD+ and ATP depletion, and subsequent cardiomyocyte apoptosis.
- PJ34 treatment mitigated myocardial injury associated with GSDMD deficiency.
Conclusions:
- GSDMD exhibits a multidirectional role in regulating cardiomyocyte death during I/R.
- GSDMD inhibition can paradoxically activate PARylation and promote apoptosis, highlighting a novel mechanism.
- These findings offer new insights into the pathophysiology of I/R injury and suggest potential therapeutic strategies targeting GSDMD.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Myocarditis I: Introduction
G-Protein Gated Ion Channels
Sensory...

